Managing Palpitations Associated with Hypothyroidism

Introduction to Management Strategies

Beta-blockers are the first-line treatment for palpitations associated with hypothyroidism, particularly when palpitations occur during levothyroxine therapy or in cases of thyrotoxicosis during treatment transition, as recommended by the American Heart Association and the American College of Cardiology 1, 2

Evaluate thyroid function tests (TSH, free T4, free T3) to determine if the patient is in a thyrotoxic phase of thyroiditis (low/normal TSH, high free T4/T3), according to the European Society of Endocrinology 3, 4
Consider cardiac evaluation including ECG to identify specific arrhythmias (particularly atrial fibrillation), as suggested by the European Society of Cardiology 5, 2
Holter monitoring is recommended for intermittent palpitations, as stated by the American Heart Association 1

For palpitations due to thyrotoxic phase of thyroiditis, beta-blockers are the first-line treatment for symptomatic control, as recommended by the European Society of Cardiology 5, 3, 4
Non-selective beta-blockers with alpha-blocking capacity are preferred for thyrotoxic phase of thyroiditis, according to the European Society of Endocrinology 4
For atrial fibrillation associated with thyroid dysfunction, beta-blockers are the first-line therapy for rate control, as recommended by the American College of Cardiology and the European Society of Cardiology 2, 5
Anticoagulation decisions should be based on standard stroke risk factors, as suggested by the European Society of Cardiology 5, 6

Patients with underlying cardiovascular disease are at higher risk for cardiac complications with thyroid hormone therapy and may require cardiology consultation and more intensive monitoring, as stated by the American College of Cardiology 2
Prophylactic beta-blockade should be considered during initial treatment for patients with underlying cardiovascular disease, as recommended by the American Heart Association 1

Refer to endocrinology for difficult-to-control thyroid function despite appropriate dose adjustments, persistent cardiac symptoms despite normalized thyroid function, or suspected thyroiditis, as suggested by the European Society of Endocrinology 3, 1, 4
Refer to cardiology for persistent or severe arrhythmias despite appropriate thyroid management, atrial fibrillation requiring rhythm control strategy, or signs of coronary insufficiency or heart failure, as recommended by the European Society of Cardiology 5, 1